These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 27163515

  • 1. Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia.
    Abdelaziz DH, Elhosseiny NM, Khaleel SA, Sabry NA, Attia AS, El-Sayed MH.
    Pediatr Blood Cancer; 2016 Sep; 63(9):1539-45. PubMed ID: 27163515
    [Abstract] [Full Text] [Related]

  • 2. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Tantawy AA, El-Bostany EA, Adly AA, Abou El Asrar M, El-Ghouroury EA, Abdulghaffar EE.
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
    [Abstract] [Full Text] [Related]

  • 3. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia].
    Zheng MM, Yue LJ, Chen XW, Wen FQ, Li CG, Yang CL, Xie C, Ding H.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar; 15(3):201-6. PubMed ID: 23498762
    [Abstract] [Full Text] [Related]

  • 4. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
    Kantar M, Kosova B, Cetingul N, Gumus S, Toroslu E, Zafer N, Topcuoglu N, Aksoylar S, Cinar M, Tetik A, Eroglu Z.
    Leuk Lymphoma; 2009 Jun; 50(6):912-7. PubMed ID: 19391036
    [Abstract] [Full Text] [Related]

  • 5. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
    Peregud-Pogorzelski J, Tetera-Rudnicka E, Kurzawski M, Brodkiewicz A, Adrianowska N, Mlynarski W, Januszkiewicz D, Drozdzik M.
    Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286
    [Abstract] [Full Text] [Related]

  • 6. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.
    Albayrak M, Konyssova U, Kaya Z, Gursel T, Guntekin S, Percin EF, Kocak U.
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026
    [Abstract] [Full Text] [Related]

  • 7. [Correlations between 6-mercaptopurine treatment-related adverse reactions in children with acute lymphoblastic leukemia and polymorphisms of thiopurine methyltransferase gene].
    Xie C, Yue LJ, Ding H, Ren YF, Yang CL, Zheng MM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):499-503. PubMed ID: 24857000
    [Abstract] [Full Text] [Related]

  • 8. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
    Eissa DS, Ahmed TM.
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238
    [Abstract] [Full Text] [Related]

  • 9. Pharmacogenetic Variants in MTHFR Gene are Significant Predictors of Methotrexate Toxicities in Bangladeshi Patients With Acute Lymphoblastic Leukemia.
    Zahra FT, Nahid NA, Islam MR, Al-Mamun MMA, Apu MNH, Nahar Z, Kabir AL, Biswas SK, Ahmed MU, Islam MS, Hasnat A.
    Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e58-e65. PubMed ID: 31884153
    [Abstract] [Full Text] [Related]

  • 10. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.
    Mahmoud LB, Mdhaffar M, Frikha R, Ghozzi H, Hakim A, Sahnoun Z, Elloumi M, Zeghal K.
    Adv Clin Exp Med; 2018 Aug; 27(8):1061-1068. PubMed ID: 29911750
    [Abstract] [Full Text] [Related]

  • 11. Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.
    El-Khodary NM, El-Haggar SM, Eid MA, Ebeid EN.
    Med Oncol; 2012 Sep; 29(3):2053-62. PubMed ID: 21644011
    [Abstract] [Full Text] [Related]

  • 12. Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population.
    Liu SG, Li ZG, Cui L, Gao C, Li WJ, Zhao XX.
    Leuk Lymphoma; 2011 Jun; 52(6):1030-40. PubMed ID: 21534867
    [Abstract] [Full Text] [Related]

  • 13. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
    Dokmanovic L, Urosevic J, Janic D, Jovanovic N, Petrucev B, Tosic N, Pavlovic S.
    Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
    [Abstract] [Full Text] [Related]

  • 14. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia.
    Kałużna E, Strauss E, Zając-Spychała O, Gowin E, Świątek-Kościelna B, Nowak J, Fichna M, Mańkowski P, Januszkiewicz-Lewandowska D.
    Eur J Pharmacol; 2015 Dec 15; 769():93-9. PubMed ID: 26528799
    [Abstract] [Full Text] [Related]

  • 15. PACSIN2 polymorphism is associated with thiopurine-induced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy.
    Smid A, Karas-Kuzelicki N, Jazbec J, Mlinaric-Rascan I.
    Sci Rep; 2016 Jul 25; 6():30244. PubMed ID: 27452984
    [Abstract] [Full Text] [Related]

  • 16. The effect of RFC G80A polymorphism in Cretan children with acute lymphoblastic leukemia and its interaction with MTHFR C677T and A1298C polymorphisms.
    Karathanasis NV, Stiakaki E, Goulielmos GΝ, Kalmanti M.
    Int J Lab Hematol; 2014 Aug 25; 36(4):425-30. PubMed ID: 24237708
    [Abstract] [Full Text] [Related]

  • 17. The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia.
    Karathanasis NV, Stiakaki E, Goulielmos GN, Kalmanti M.
    Genet Test Mol Biomarkers; 2011 Aug 25; 15(1-2):5-10. PubMed ID: 21117954
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
    D'Angelo V, Ramaglia M, Iannotta A, Crisci S, Indolfi P, Francese M, Affinita MC, Pecoraro G, Napolitano A, Fusco C, Oreste M, Indolfi C, Casale F.
    Cancer Chemother Pharmacol; 2011 Nov 25; 68(5):1339-46. PubMed ID: 21590445
    [Abstract] [Full Text] [Related]

  • 19. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.
    Zgheib NK, Akika R, Mahfouz R, Aridi CA, Ghanem KM, Saab R, Abboud MR, Tarek N, El Solh H, Muwakkit SA.
    Pediatr Blood Cancer; 2017 Jan 25; 64(1):146-150. PubMed ID: 27577869
    [Abstract] [Full Text] [Related]

  • 20. Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.
    Tantawy AAG, Ebeid FSE, Adly AAM, El-Ghoroury E, Mostafa M.
    J Genet; 2017 Dec 25; 96(6):905-910. PubMed ID: 29321348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.